In 1996, Braun et al. detected −58T/C variations in the BDKRB2 promoter region and found that these could lead to a reduction in BDKRB2 transcription, which might be associated with the pathogenesis of essential hypertension (EH) [3]. This evidence concerns the gene BDKRB2 and essential hypertension.